Showing results (2521-2530 of 2,591) with videos related to
Sort By:
Pageof 260
Molecular Oncology|March 12, 2024
From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021-lessons learned and implicationsJulio Celis, Ulrik RingborgMolecular Oncology|July 3, 2024
Immune evasion: An imperative and consequence of MYC deregulationBastian Krenz, Jongkuen Lee, Toshitha Kannan, et al.Molecular Oncology|July 20, 2024
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathwayXiaopei Shen, Jie Tan, Rengyun Liu, et al.Molecular Oncology|July 5, 2024
Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferationZoe Lombardi, Lucia Gardini, Anatolii V Kashchuk, et al.Molecular Oncology|April 11, 2024
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesisYonghwan Shin, Sungmin Kim, Gangning Liang, et al.Molecular Oncology|April 1, 2024
TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesisAkshatha N Srinivas, Diwakar Suresh, Prashant M Vishwanath, et al.Molecular Oncology|March 27, 2024
The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiationPetra Marttila, Nadilly Bonagas, Christina Chalkiadaki, et al.Molecular Oncology|January 24, 2024
Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activityHenna Pehkonen, Artemis Filippou, Juho Väänänen, et al.Molecular Oncology|January 26, 2024
Deciphering metabolic crosstalk in context: lessons from inflammatory diseasesFenne W M Verheijen, Thi N M Tran, Jung-Chin Chang, et al.Molecular Oncology|February 3, 2024
Genetic and non-genetic drug resistance: Darwin or Lamarck?Mariangela RussoPageof 260